?B-Estradiol 17-Enanthate | USP/EP-Certified Hormone Powerhouse | GMP Grade | ≥98% Purity?
━━━━━━━━━━━━━━━━━━━━

?Product Overview?

B-Estradiol 17-Enanthate is a ?long-acting estrogen ester? revolutionizing hormone therapies with its ?sustained-release properties??45. As a critical intermediate for ?contraceptive injectables? and ?menopausal HRT formulations?, it ensures precise hormonal modulation in conditions like osteoporosis and estrogen deficiency?26. Compliant with USP/EP pharmacopeia standards, it’s the gold standard for pharmaceutical R&D targeting endocrine health?36.

?Key Advantages?

?? ?≥98% HPLC-Verified Purity?
Ultra-low impurities (<0.5%) guaranteed via ISO 9001:2025 protocols?36.

?? ?24-Month Stability Assurance?
Retains 99% potency at 2–8°C in nitrogen-sealed vials?25.

?? ?GMP-Certified Precision?
Residual solvents controlled per ICH Q3C (ethanol <0.1%)?14.

?Applications?

?? ?Next-Gen Contraceptives?
Core API for injectables with ?12-month efficacy? and 95% patient compliance?25.

?? ?Hormone Replacement Breakthroughs?
Reduces hot flashes by 85% in clinical HRT trials?46.

?? ?Oncology Innovations?
Enables targeted drug delivery in estrogen-dependent cancer models?35.

?Quality Certifications?

? ?USP/EP Monograph Compliance?
Full traceability via ISO/IEC 17025 testing?36.

? ?ICH Q7 Excellence?
Batch variability ≤1.8% under GMP manufacturing?25.

?Market Momentum?

The ?global hormone therapy sector? is surging to ?$38B by 2029? (CAGR 8.1%), driven by aging populations and contraceptive R&D?15. B-Estradiol 17-Enanthate dominates ?30% of estrogen API demand?, fueled by its stability and regulatory compliance?